SMC recommends elmiron® for the treatment of Bladder Pain Syndrome

Consilient Health welcomes the decision by the SMC, Scottish Medicines Consortium, to recommend elmiron® (pentosan polysulfate sodium) for use by the NHS in Scotland within its licensed indication according to its marketing authorisation.

Amanda Paxon, UK Country Manager at Consilient Health responded, “As a company we are delighted with the SMC decision to recommend elmiron® according to its marketing authorisation. This condition is debilitating and Scottish patients now have another choice in the treatment of their condition.”

View more news and events